UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 69

Sortiert nach

OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation

Nature communications, 2020-03, Vol.11 (1), p.1487-1487, Article 1487

2020

Link zum Volltext

Verfügbarkeit prüfen

Elimination of large tumors in mice by mRNA-encoded bispecific antibodies

Nature medicine, 2017-07, Vol.23 (7), p.815-817

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeting the tumor vasculature with engineered cystine-knot miniproteins

Nature communications, 2020-01, Vol.11 (1), p.295-295, Article 295

2020

Link zum Volltext

Verfügbarkeit prüfen

Exploiting the Mutanome for Tumor Vaccination

Cancer research (Chicago, Ill.), 2012-03, Vol.72 (5), p.1081-1091

2012

Link zum Volltext

Verfügbarkeit prüfen

Racing for a SARS‐CoV‐2 vaccine

EMBO molecular medicine, 2021-11, Vol.13 (11), p.e15145-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial

Vaccine, 2022-03, Vol.40 (10), p.1483-1492

2022

Link zum Volltext

Verfügbarkeit prüfen

Claudin 18.2 is a target for IMAB362 antibody in pancreatic neoplasms

International journal of cancer, 2014-02, Vol.134 (3), p.731-739

2014

Link zum Volltext

Verfügbarkeit prüfen

Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non‐small‐cell lung cancer

International journal of cancer, 2014-11, Vol.135 (9), p.2206-2214

2014

Link zum Volltext

Verfügbarkeit prüfen

Induction of immunosuppressive functions and NF-κB by FLIP in monocytes

Nature communications, 2018-12, Vol.9 (1), p.5193-13, Article 5193

2018

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes

International journal of molecular sciences, 2020-09, Vol.21 (19), p.7178

2020

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive Genomic and Transcriptomic Analysis of Three Synchronous Primary Tumours and a Recurrence from a Head and Neck Cancer Patient

International journal of molecular sciences, 2021-07, Vol.22 (14), p.7583

2021

Link zum Volltext

Verfügbarkeit prüfen

The regulatory landscape for actively personalized cancer immunotherapies

Nature biotechnology, 2013-10, Vol.31 (10), p.880-882

2013

Link zum Volltext

Verfügbarkeit prüfen

Challenges towards the realization of individualized cancer vaccines

Nature biomedical engineering, 2018-08, Vol.2 (8), p.566

2018

Link zum Volltext

Verfügbarkeit prüfen

FLT3 Ligand Enhances the Cancer Therapeutic Potency of Naked RNA Vaccines

Cancer research (Chicago, Ill.), 2011-10, Vol.71 (19), p.6132-6142

2011

Link zum Volltext

Verfügbarkeit prüfen

Complex Cellular Responses of Helicobacter pylori-Colonized Gastric Adenocarcinoma Cells

Infection and Immunity, 2011-06, Vol.79 (6), p.2362-2371

2011

Link zum Volltext

Verfügbarkeit prüfen

A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes

Cancer research (Chicago, Ill.), 2007-10, Vol.67 (19), p.9528-9534

2007

Link zum Volltext

Verfügbarkeit prüfen

1181 GEN1042-mIgG2a, an Fc-inert mouse-human chimeric variant of GEN1042 (DuoBody®-CD40x4–1BB), exhibits in vivo antitumor activity and peripheral immune modulation

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1302-A1302

2023

Link zum Volltext

Verfügbarkeit prüfen

Highly Specific Auto-Antibodies against Claudin-18 Isoform 2 Induced by a Chimeric HBcAg Virus-Like Particle Vaccine Kill Tumor Cells and Inhibit the Growth of Lung Metastases

Cancer research (Chicago, Ill.), 2011-01, Vol.71 (2), p.516-527

2011

Link zum Volltext

Verfügbarkeit prüfen

Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue

Diagnostic pathology, 2018-10, Vol.13 (1), p.83-83, Article 83

2018

Link zum Volltext

Verfügbarkeit prüfen

958 BNT211: a phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A1008-A1008

2021

Link zum Volltext

Verfügbarkeit prüfen

786 Dose selection for DuoBody®-PD-L1×4-1BB (GEN1046) using a semimechanistic pharmacokinetics/pharmacodynamics model that leverages preclinical and clinical data

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A821-A821

2021

Link zum Volltext

Verfügbarkeit prüfen

Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological Malignancy

Indian journal of hematology & blood transfusion, 2021-01, Vol.37 (1), p.67-75

2021

Link zum Volltext

Verfügbarkeit prüfen

525 Preliminary safety, PK/PD and efficacy results from a first-in-human phase I/IIa clinical trial of BNT411, a systemic Toll-like receptor 7 agonist in patients with solid tumors

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A555-A555

2021

Link zum Volltext

Verfügbarkeit prüfen

A Testicular Antigen Aberrantly Expressed in Human Cancers Detected by Autologous Antibody Screening

Proceedings of the National Academy of Sciences - PNAS, 1997-03, Vol.94 (5), p.1914-1918

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 69

Suche als RSS-Feed

Aktive Filter

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(69)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(55)
Humans
(43)
Life Sciences & Biomedicine
(40)
Oncology
(23)
Biological And Medical Sciences
(19)
Cancer
(19)
Immunotherapy
(19)
Lymphocytes
(18)
Medical Sciences
(18)
Antigens
(17)
Female
(16)
Animals
(15)
Patients
(14)
Science & Technology - Other Topics
(14)
Multidisciplinary Sciences
(13)
Vaccines
(13)
Male
(12)
Melanoma
(12)
Mice
(12)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation

Elimination of large tumors in mice by mRNA-encoded bispecific antibodies

Targeting the tumor vasculature with engineered cystine-knot miniproteins

Exploiting the Mutanome for Tumor Vaccination

Racing for a SARS‐CoV‐2 vaccine

Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial

Claudin 18.2 is a target for IMAB362 antibody in pancreatic neoplasms

Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non‐small‐cell lung cancer

CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial

Induction of immunosuppressive functions and NF-κB by FLIP in monocytes

Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes

Comprehensive Genomic and Transcriptomic Analysis of Three Synchronous Primary Tumours and a Recurrence from a Head and Neck Cancer Patient

The regulatory landscape for actively personalized cancer immunotherapies

Challenges towards the realization of individualized cancer vaccines

FLT3 Ligand Enhances the Cancer Therapeutic Potency of Naked RNA Vaccines

Complex Cellular Responses of Helicobacter pylori-Colonized Gastric Adenocarcinoma Cells

A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes

1181 GEN1042-mIgG2a, an Fc-inert mouse-human chimeric variant of GEN1042 (DuoBody®-CD40x4–1BB), exhibits in vivo antitumor activity and peripheral immune modulation

Highly Specific Auto-Antibodies against Claudin-18 Isoform 2 Induced by a Chimeric HBcAg Virus-Like Particle Vaccine Kill Tumor Cells and Inhibit the Growth of Lung Metastases

Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue

958 BNT211: a phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors

786 Dose selection for DuoBody®-PD-L1×4-1BB (GEN1046) using a semimechanistic pharmacokinetics/pharmacodynamics model that leverages preclinical and clinical data

Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological Malignancy

525 Preliminary safety, PK/PD and efficacy results from a first-in-human phase I/IIa clinical trial of BNT411, a systemic Toll-like receptor 7 agonist in patients with solid tumors

A Testicular Antigen Aberrantly Expressed in Human Cancers Detected by Autologous Antibody Screening

Aktive Filter

Suchergebnisse filtern